Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

INTRODUCTION: This ongoing, prospective, open-label, non-comparative, multicenter phase IV study is evaluating the safety and efficacy of recombinant human growth hormone (rhGH; Omnitrope(®), Sandoz GmbH) in short children born small for gestational age (SGA). Here we report data from patients who h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Ther
Main Authors: Schwarz, Hans-Peter, Walczak, Mieczysław, Birkholz-Walerzak, Dorota, Szalecki, Mieczyslaw, Nanu, Michaela, Woehling, Heike, Schuck, Ellen
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4833801/
https://ncbi.nlm.nih.gov/pubmed/26886776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0301-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados